Analgesic potential of different available commercial brands of botulinum neurotoxin-A in formalin-induced orofacial pain in mice
The use of botulinum neurotoxin-A (BoNT-A) is an alternative for the management of orofacial pain disorders. Although only Botox has labeled, there are other commercial brands available for use, among them: Dysport, Botulift, Prosigne, and Xeomin. The objective of the present study was to evaluate t...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Toxicon: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590171021000199 |